The participation of human papillomaviruses in the development of cervical cancer is supported by the demonstration in the tumor cells of papillomavirus group-specific antigen and viral particles. In this project we will attempt to induce neoplastic progression of papillomavirus-infected lesions of human cervix by treating the grafts with agents which may represent additional risk factors for the development of cervical cancer. Some of these agents include benzopyrene, n-methylnitrosamine, estrogens, and herpes simplex virus type 2.
Ghim, S; Christensen, N D; Kreider, J W et al. (1991) Comparison of neutralization of BPV-1 infection of C127 cells and bovine fetal skin xenografts. Int J Cancer 49:285-9 |
Kreider, J W; Patrick, S D; Cladel, N M et al. (1990) Experimental infection with human papillomavirus type 1 of human hand and foot skin. Virology 177:415-7 |
Kreider, J W; Howett, M K; Leure-Dupree, A E et al. (1987) Laboratory production in vivo of infectious human papillomavirus type 11. J Virol 61:590-3 |